Minimally invasive (MI) surgeries/procedures are rapidly becoming one of the leading approaches used to treat various cardiovascular ailments, especially blood clots. Over the years, majority of the MI cardiovascular surgeries have been increasingly using coronary stents, to increase the success rate of surgeries and reduce the procedure and recovery time. Coronary stents are used as an important component in percutaneous coronary revascularization. The use of coronary stents has enhanced the efficacy, and safety of stenting procedures.

PART 01: Executive summary

PART 02: Scope of the report

Market overview

Top-vendor offerings

PART 03: Market research methodology

Research methodology

Economic indicators

PART 04: Introduction

Key market highlights

PART 05: Market landscape

Market overview

Market size and forecast

Five forces analysis

PART 06: Market segmentation by material

Polymeric stents

Metallic stents

PART 07: Market segmentation by application

Market overview

PART 08: Market segmentation by end-user

Hospitals

ASCs

PART 09: Geographical segmentation

Bioabsorbable stents market in the Americas

Bioabsorbable stents market in EMEA

Bioabsorbable stents market in APAC

PART 10: Market drivers

Increasing prevalence of CADs

Growing demand for MI procedures

Growing diabetic population

PART 11: Impact of drivers

PART 12: Market challenges

Stringent regulation for approval of devices

Threat of substitute products

Increasing competition among vendors

PART 13: Impact of drivers and challenges

PART 14: Market trends

Advent of metallic stents

Growing popularity of hybrid procedures

Alternative use of vascular stents

PART 15: Vendor landscape

Competitive landscape analysis

PART 16: Key vendor analysis

Boston Scientific

Abbott Laboratories

Elixir Medical

Kyoto Medical Planning

Other prominent vendors

PART 17: Appendix

List of abbreviations

PART 18: Explore Technavio